MedPath

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients

Conditions
Appendicitis Acute
Interventions
Diagnostic Test: Blood specimen collection
Diagnostic Test: Saliva specimen collection
Registration Number
NCT05093660
Lead Sponsor
KBC Split
Brief Summary

Acute appendicitis is a common and potentially serious medical condition which can be difficult to diagnose, especially in pediatric patients. To help recognize patients with acute appendicitis, number of laboratory and radiological test are used. Previous research has shown that Circulating Human Leucine-rich α-2-glycoprotein (LGR1) in the blood can be elevated in pediatric patients with acute appendicitis. The aim of this research is to analyse whether LGR1 levels in saliva can be used as a less invasive diagnostic method in pediatric patients with suspected acute appendicitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • children with age from 5 do 17 with acute abdominal pain
  • children with clinical signs of appendicitis
Exclusion Criteria
  • previous diagnosis of chronic and/or malignant disease
  • children which had previous abdominal surgery
  • pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients without acute appendicitisBlood specimen collectionPatients without acute appendicitis, after laboratory, clinical and/or radiological exclusion of acute admittance.
Patients with acute appendicitisBlood specimen collectionPatients with acute appendicitis, after surgery and with pathohistological specimen confirmation.
Patients without acute appendicitisSaliva specimen collectionPatients without acute appendicitis, after laboratory, clinical and/or radiological exclusion of acute admittance.
Patients with acute appendicitisSaliva specimen collectionPatients with acute appendicitis, after surgery and with pathohistological specimen confirmation.
Primary Outcome Measures
NameTimeMethod
Level of LGR1 protein in blood72 hours

Levels of LGR1 protein in blood and saliva as measured by ELISA test

Level of LGR1 protein saliva72 hours

Levels of LGR1 protein in saliva as measured by ELISA test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Split

🇭🇷

Split, Splitsko-dalmatinska, Croatia

© Copyright 2025. All Rights Reserved by MedPath